Skip to content
mesothelioma chemotherapy

Just the word cancer is frightening enough by itself. Even the threat of a possible diagnosis causes anxiety and a fear of death unlike any other disease. However, it’s important to realize that cancer does not have to be a death sentence. Early detection is the best tool modern medicine has to stop cancer and prevent it from spreading throughout the body. It’s a fact that localized cancer in itself isn’t usually life threatening. It’s when the cancerous cells migrate throughout the body that death often occurs. Since early detection is the best tool in beating cancer, it is critical that the symptoms are recognized as soon as possible so that treatment can begin before the cancer spreads.

Aside from the normal symptoms such as unusual lumps, a change in a mole or wart, troubles with the digestive system, and other common signs, there are also two serious conditions that are often times a warning sign for cancer.

 

Name:
Phone Number:
E-mail:
Street Address:
City, State, Zip:
Comments or
Questions:
**(Packet includes information on treatment, clinical trials, cancer links, how to access legal and financial resources, and frequently asked legal questions with answers provided by Cooper, Hart, Leggiero & Whitehead, PLLC.). By filling out the above form you consent to being contacted by Cooper, Hart, Leggiero & Whitehead regarding potentially retaining legal services.


This website is sponsored by Brad Cooper* of The Cooper, Hart, Leggiero, & Whitehead, PLLC. Cooper, Hart, Leggiero, & Whitehead is located in The Woodlands, Texas (Greater Houston Area) and can be reached toll free at 1-800-998-9729 for more information on mesothelioma. Brad Cooper is not a medical doctor. The information on these pages is for the education of mesothelioma patients and their families regarding potential medical and legal options. Patients are advised to consult with a medical doctor.

*  Licensed by the Supreme Court  of Texas.

 

 

 

The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a clinical practice guideline.

Advances in the systemic therapy of malignant pleural mesothelioma

Kinase Inhibitors for Mesothelioma Treatment

journal abstracts

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

The second wave in kinase cancer drugs

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma


Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.